Science ❯Biotechnology ❯Vaccine Development
H5N1 Vaccine mRNA Vaccine Trials Phase II Trials Regulatory Affairs mRNA Vaccines
New research indicates Moderna's mRNA-1769 vaccine outperforms existing options in reducing symptoms and transmission.
